VOL. 25 · NO. 2 | May 2010
Statist. Sci. 25 (2), (May 2010) Open Access
No abstract available
Statist. Sci. 25 (2), (May 2010) Open Access
No abstract available
Bradley Efron
Statist. Sci. 25 (2), 145-157, (May 2010) DOI: 10.1214/09-STS308 Open Access
KEYWORDS: Statistical learning, experience of others, Bayesian and frequentist, James–Stein, Benjamini–Hochberg, False discovery rates, effect size
Sander Greenland
Statist. Sci. 25 (2), 158-161, (May 2010) DOI: 10.1214/10-STS308A Open Access
No abstract available
Andrew Gelman
Statist. Sci. 25 (2), 162-165, (May 2010) DOI: 10.1214/10-STS308B Open Access
No abstract available
Robert E. Kass
Statist. Sci. 25 (2), 166-169, (May 2010) DOI: 10.1214/10-STS308C Open Access
KEYWORDS: Bayesian, decision theory, prior information, statistical pragmatism, statistical science
Bradley Efron
Statist. Sci. 25 (2), 170-171, (May 2010) DOI: 10.1214/10-STS308REJ Open Access
No abstract available
Chris Sherlock, Paul Fearnhead, Gareth O. Roberts
Statist. Sci. 25 (2), 172-190, (May 2010) DOI: 10.1214/10-STS327 Open Access
KEYWORDS: Random walk Metropolis, Metropolis–Hastings, MCMC, adaptive MCMC, MMPP
Ying Kuen Cheung
Statist. Sci. 25 (2), 191-201, (May 2010) DOI: 10.1214/10-STS334 Open Access
KEYWORDS: Coherence, dichotomized data, discrete barrier, ethics, indifference interval, maximum likelihood recursion, unbiasedness, virtual observations
John O’Quigley, Mark Conaway
Statist. Sci. 25 (2), 202-216, (May 2010) DOI: 10.1214/10-STS332 Open Access
KEYWORDS: Bayesian methods, clinical trial, continual reassessment method, dose escalation, dose-finding studies, efficacy, maximum likelihood, maximum tolerated dose, most successful dose, Phase 1 trials, Phase 2 trials, toxicity
Mourad Tighiouart, André Rogatko
Statist. Sci. 25 (2), 217-226, (May 2010) DOI: 10.1214/10-STS333 Open Access
KEYWORDS: Cancer phase I trials, dose-limiting toxicity, escalation with overdose control, tolerated dose, optimal Bayesian feasible
Peter F. Thall
Statist. Sci. 25 (2), 227-244, (May 2010) DOI: 10.1214/09-STS315 Open Access
KEYWORDS: adaptive design, Bayesian design, clinical trial, dose-finding, phase I trial, phase I/II trial
Jay Bartroff, Tze Leung Lai
Statist. Sci. 25 (2), 245-257, (May 2010) DOI: 10.1214/10-STS317 Open Access
KEYWORDS: dynamic programming, maximum tolerated dose, Monte Carlo, rollout, stochastic optimization
Christian Genest, Gordon Brackstone
Statist. Sci. 25 (2), 258-273, (May 2010) DOI: 10.1214/08-STS272 Open Access
KEYWORDS: AT&T, Canadian census, probability plots, Shapiro–Wilk statistic, Statistical Society of Canada, Statistics Canada
Back to Top